AMPE (OTC)
AMPIO PHARMS INC
—
Change: —
Prev close: —
Company Information
- Exchange
- OTC Link
- Sector
- —
- Industry
- —
- CEO
- —
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- —
- Employees
- —
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2023 (Q3)
|
$-1.53 | $0.00 | +0.0000 | +0.00% |
|
Jun 2022 (Q2)
|
$-0.20 | $-0.41 | +0.2080 | +50.98% |
|
Mar 2022 (Q1)
|
$-0.40 | $-0.41 | +0.0080 | +1.96% |
|
Mar 2021 (Q4)
|
$-0.80 | $-0.41 | -0.3920 | -96.08% |
Financial Statements
| Nonoperating Income/Loss | $942.00K |
| Operating Expenses | $9.57M |
| Research and Development | $2.44M |
| Other Operating Expenses | $7.14M |
| Income/Loss From Continuing Operations After Tax | -$8.63M |
| Income/Loss From Continuing Operations Before Tax | -$8.63M |
| Net Income/Loss | -$8.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$10.66 |
| Diluted Earnings Per Share | -$10.66 |
| Basic Average Shares | 810,113 |
| Diluted Average Shares | 810,113 |
| Assets | $5.74M |
| Current Assets | $5.74M |
| Noncurrent Assets | $0.00 |
| Fixed Assets | $0.00 |
| Liabilities | $2.38M |
| Current Liabilities | $2.38M |
| Accounts Payable | $750.00K |
| Other Current Liabilities | $1.63M |
| Noncurrent Liabilities | $0.00 |
| Equity | $3.36M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $3.36M |
| Liabilities And Equity | $5.74M |
| Net Cash Flow From Operating Activities | -$8.56M |
| Net Cash Flow From Operating Activities, Continuing | -$8.56M |
| Net Cash Flow From Investing Activities | $0.00 |
| Net Cash Flow From Financing Activities | $0.00 |
| Net Cash Flow | -$8.56M |
| Net Cash Flow, Continuing | -$8.56M |
| Comprehensive Income/Loss | -$8.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.63M |
| Other Comprehensive Income/Loss | $0.00 |